{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:34:52Z","timestamp":1782311692551,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["268505"],"award-info":[{"award-number":["268505"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["275922"],"award-info":[{"award-number":["275922"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["297094"],"award-info":[{"award-number":["297094"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"People Programme"},{"name":"European Union\u2019s Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["317250"],"award-info":[{"award-number":["317250"]}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltonen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ymthe.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T08:49:12Z","timestamp":1548578952000},"page":"600-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury"],"prefix":"10.1016","volume":"27","author":[{"given":"Johanna","family":"Magga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Kilpi\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha J.","family":"Hulmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saija","family":"Taponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Rahtu-Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Alakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ulvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Alitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Ritvos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Kerkel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2019.01.013_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCRESAHA.110.223792","article-title":"Cardiopoietic factors: extracellular signals for cardiac lineage commitment","volume":"108","author":"Noseda","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib2","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/me.2008-0290","article-title":"Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators","volume":"22","author":"Souza","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib3","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.01.013_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.013_bib5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cca.2014.03.021","article-title":"Myostatin - From the Mighty Mouse to cardiovascular disease and cachexia","volume":"433","author":"Dschietzig","year":"2014","journal-title":"Clinica Chim Acta"},{"key":"10.1016\/j.ymthe.2019.01.013_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2015.10.006","article-title":"Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration","volume":"156","author":"Rochette","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.013_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.872200","article-title":"Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury","volume":"120","author":"Oshima","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.01.013_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cyto.2014.06.017","article-title":"Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury","volume":"69","author":"Chen","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.ymthe.2019.01.013_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2008.10.027","article-title":"Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention","volume":"401","author":"Miyoshi","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymthe.2019.01.013_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2014.12.057","article-title":"Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy","volume":"457","author":"Castillero","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2019.01.013_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.hlc.2017.05.138","article-title":"Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction","volume":"27","author":"Lim","year":"2018","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ymthe.2019.01.013_bib13","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1038\/s41598-018-23042-w","article-title":"Mechanical stretch induced transcriptomic profiles in cardiac myocytes","volume":"8","author":"Rys\u00e4","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.013_bib14","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2019.01.013_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymthe.2019.01.013_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib17","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.M110.114959","article-title":"Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb","volume":"285","author":"Sako","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2019.01.013_bib18","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1152\/ajpendo.00389.2012","article-title":"Muscle protein synthesis, mTORC1\/MAPK\/Hippo signaling, and capillary density are altered by blocking of myostatin and activins","volume":"304","author":"Hulmi","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2019.01.013_bib19","doi-asserted-by":"crossref","first-page":"32695","DOI":"10.1038\/srep32695","article-title":"Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes","volume":"6","author":"Nissinen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.013_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jcsm.12265","article-title":"Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle","volume":"9","author":"Hulmi","year":"2018","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ymthe.2019.01.013_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.109.197996","article-title":"Role of glycogen synthase kinase-3beta in cardioprotection","volume":"104","author":"Juhaszova","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.10.009","article-title":"The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair","volume":"359","author":"de Kretser","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","article-title":"C\/EBP\u03b2 controls exercise-induced cardiac growth and protects against pathological cardiac remodeling","volume":"143","author":"Bostr\u00f6m","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.013_bib24","doi-asserted-by":"crossref","first-page":"e85904","DOI":"10.1172\/jci.insight.85904","article-title":"CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury","volume":"1","author":"Bezzerides","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2019.01.013_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ymthe.2019.01.013_bib26","doi-asserted-by":"crossref","first-page":"e002423","DOI":"10.1161\/JAHA.115.002423","article-title":"Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events","volume":"4","author":"Kerkel\u00e4","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2019.01.013_bib27","doi-asserted-by":"crossref","first-page":"43958","DOI":"10.1038\/srep43958","article-title":"Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling","volume":"7","author":"Pavo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.013_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.01.013_bib29","first-page":"E5266","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.01.013_bib30","doi-asserted-by":"crossref","first-page":"15153","DOI":"10.1038\/ncomms15153","article-title":"Activin A more prominently regulates muscle mass in primates than does GDF8","volume":"8","author":"Latres","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.01.013_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2019.01.013_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/rej.2010.1065","article-title":"Altered primary and secondary myogenesis in the myostatin-null mouse","volume":"13","author":"Matsakas","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1096\/fj.05-5125fje","article-title":"Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy","volume":"20","author":"Steelman","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2019.01.013_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1152\/physiolgenomics.00054.2009","article-title":"Skeletal muscle gene expression after myostatin knockout in mature mice","volume":"38","author":"Welle","year":"2009","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymthe.2019.01.013_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1152\/japplphysiol.00866.2009","article-title":"Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type","volume":"109","author":"Cadena","year":"2010","journal-title":"J.\u00a0Appl. Physiol. (1985)"},{"key":"10.1016\/j.ymthe.2019.01.013_bib36","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41467-017-01950-1","article-title":"Opposite effects of Activin type 2 receptor ligands on cardiomyocyte proliferation during development and repair","volume":"8","author":"Dogra","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.01.013_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2014.05.013","article-title":"Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives","volume":"144","author":"Javadov","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2019.01.013_bib38","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1038\/s41467-018-05439-3","article-title":"JNK regulates muscle remodeling via myostatin\/SMAD inhibition","volume":"9","author":"Lessard","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2019.01.013_bib39","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.yjmcc.2010.01.010","article-title":"Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway","volume":"48","author":"Pachori","year":"2010","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib40","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.112.115089","article-title":"Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models","volume":"126","author":"Ogura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.01.013_bib41","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1161\/CIRCULATIONAHA.108.767673","article-title":"Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart","volume":"117","author":"Oshima","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2019.01.013_bib42","doi-asserted-by":"crossref","first-page":"e004486","DOI":"10.1161\/CIRCHEARTFAILURE.117.004486","article-title":"Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure","volume":"11","author":"Seki","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ymthe.2019.01.013_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/10320","article-title":"Regulation of anterior\/posterior patterning of the axial skeleton by growth\/differentiation factor 11","volume":"22","author":"McPherron","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2019.01.013_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-213X-9-24","article-title":"Redundancy of myostatin and growth\/differentiation factor 11 function","volume":"9","author":"McPherron","year":"2009","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib45","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2013.04.015","article-title":"Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy","volume":"153","author":"Loffredo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.013_bib46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cmet.2016.05.023","article-title":"Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease","volume":"23","author":"Schafer","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2019.01.013_bib47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.307962","article-title":"Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?","volume":"118","author":"Harper","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cmet.2015.05.010","article-title":"GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration","volume":"22","author":"Egerman","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2019.01.013_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15252\/emmm.201607231","article-title":"Supraphysiological levels of GDF11 induce striated muscle atrophy","volume":"9","author":"Hammers","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2019.01.013_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00395-016-0593-y","article-title":"Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury","volume":"112","author":"Du","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib51","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2011.10.124","article-title":"Myostatin induces autophagy in skeletal muscle in\u00a0vitro","volume":"415","author":"Lee","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymthe.2019.01.013_bib52","doi-asserted-by":"crossref","first-page":"H728","DOI":"10.1152\/ajpheart.00068.2016","article-title":"A systems genetics approach identifies Trp53inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response","volume":"312","author":"Seldin","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib53","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.115.304185","article-title":"Myostatin regulates energy homeostasis in the heart and prevents heart failure","volume":"115","author":"Biesemann","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2019.01.013_bib55","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2019.01.013_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2019.01.013_bib57","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1\u03b1 isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.013_bib58","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1210\/en.2012-1016","article-title":"A novel therapeutic approach to treating obesity through modulation of TGF\u03b2 signaling","volume":"153","author":"Koncarevic","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2019.01.013_bib59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.yjmcc.2009.02.026","article-title":"Cardioprotection by metabolic shut-down and gradual wake-up","volume":"46","author":"Burwell","year":"2009","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib60","doi-asserted-by":"crossref","first-page":"121900","DOI":"10.1172\/jci.insight.121900","article-title":"Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia\/reperfusion injury","volume":"3","author":"Basheer","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2019.01.013_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13395-015-0060-8","article-title":"Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice","volume":"5","author":"Latres","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2019.01.013_bib62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2019.01.013_bib63","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2019.01.013_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2019.01.013_bib65","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41598-018-20524-9","article-title":"Blocking extracellular activation of myostatin as a strategy for treating muscle wasting","volume":"8","author":"Pirruccello-Straub","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2019.01.013_bib66","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619300164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001619300164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:37:19Z","timestamp":1662856639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001619300164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1525001619300164"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}